The predominance of p53 mutations in the major subset of CRC, which is related to the APC inactivation, suggests that the ability of wild type p53 to restrain the deregulated wild type β-catenin is an essential component of its tumor suppressor function. The gene discussed is APC; the disease is colorectal carcinoma.